Investigation of the factors associated with circulating soluble CD36 levels in patients with HCV-related chronic liver disease
Authors:
- Takashi HimotoTHTakashi Himoto
- Joji TaniJTJoji Tani
- Asahiro MorishitaAMAsahiro Morishita
- Hirohito YoneyamaHYHirohito Yoneyama
- Kazutaka KurokohchiKKKazutaka Kurokohchi
- Michio InukaiMIMichio Inukai
- Hisashi MasugataHMHisashi Masugata
- Fuminori GodaFGFuminori Goda
- Shoichi SendaSSShoichi Senda
- Reiji HabaRHReiji Haba
- Masaki UenoMUMasaki Ueno
Open Access
- 9 September 2013
- journal article
- research article
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 5 (1) , 51
Abstract
CD36, a class B scavenger receptor, participates in the pathogenesis of metabolic dysregulation such as insulin resistance, hepatic steatosis, and atherosclerosis. Persistent hepatitis C virus (HCV) infection often evokes these metabolic abnormalities. The primary purpose of this study was to investigate the role of CD36 in the pathogenesis of insulin resistance and hepatic steatosis caused by chronic HCV infection. Forty-five patients with HCV-related chronic liver disease (CLD-C) were enrolled in this study. CD36 expression in the liver specimen was examined by an immunohistochemical procedure. The concentrations of circulating soluble form of CD36 (sCD36) and oxLDL were determined by the enzyme-linked innunosorbent assay. Insulin resistance was estimated by the values of HOMA-IR. Moderate to extensive hepatic CD36 expression was observed in the sinusoids of all enrolled CLD-C patients. CD36-positive sinusoids appeared to be identical to Kupffer cells. The severity of CD36 expression in the hepatic sinusoids was significantly correlated with the sCD36 level in sera of patients with CLD-C. The serum sCD36 levels were significantly correlated with body mass index and serum oxLDL levels in those patients. However, the serum sCD36 concentrations were independent of the values of HOMA-IR and the severity of hepatic steatosis. These data suggest that the serum sCD36 levels reflect the severity of CD36 expression on the Kupffer cells in patients with CLD-C, and that the serum sCD36 levels were associated with obesity, although the levels were independent of insulin resistance and hepatic steatosis in those patients.Keywords
This publication has 41 references indexed in Scilit:
- Scavenger Receptor CD36 Expression Contributes to Adipose Tissue Inflammation and Cell Death in Diet-Induced ObesityPLOS ONE, 2012
- Chronic Hepatitis C InfectionNew England Journal of Medicine, 2011
- Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis CGut, 2011
- A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signallingCardiovascular Research, 2010
- Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis CExperimental and Therapeutic Medicine, 2010
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Circulating soluble CD36 is a novel marker of liver injury in subjects with altered glucose toleranceThe Journal of Nutritional Biochemistry, 2009
- Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81Hepatology, 2007
- Effect of Treatment With Peginterferon or Interferon Alfa–2B and Ribavirin on Steatosis in Patients Infected With Hepatitis CHepatology, 2003
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001